Human Psychopharmacology Clinical and Experimental · 1997 · 32 citations · 5 references
Life SciencesNeurologyNeuroscienceMovement DisordersNeurogeneticsNeuropathologyDisease Susceptibility LociGenetic SusceptibilityAbnormal Involuntary Movement ScaleAntipsychotic-induced Tardive DyskinesiaTardive DystoniaTardive Tremor
In order to find a genetic marker for vulnerability to tardive dyskinesia (TD), we looked for an association between vulnerability to TD and polymorphic sites in the gene loci encoding the dopamine D2 receptor (Nco I site), the dopamine D3 receptor (Bal I site), and the dopamine transporter (40-bp, tandem repeat polymorphism). No significant difference was observed in the allele and genotype frequencies of any of the polymorphic sites examined, when comparing psychiatric patients who were specifically vulnerable to TD (n = 49) and those who were not (n = 56). These results suggest that the polymorphic gene loci examined in the present study are unlikely to be of major aetiologic importance in the development of TD. © 1997 John Wiley & Sons, Ltd.
5
A 40-nucleotide repeat polymorphism in the human dopamine transporter gene
Akira Sano, Keiji Kondoh, Yasuo Kakimoto et al. · Human Genetics · 1993 · 140 citations